Position in XGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$103,707
-$88,293 QoQ
Shares Held
34,569
+9.5% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $1,656,514,763 across 27 Diagnostics & Research names. XGN ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
1,025,240 | $305,316,471 | |
| 2 | DHR |
Danaher Corp /De/
|
1,428,248 | $270,795,820 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
432,602 | $207,731,153 | |
| 4 | A |
Agilent Technologies, Inc.
|
1,695,923 | $193,301,303 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
302,848 | $148,858,876 | |
| 6 | ICLR |
Icon PLC
|
1,198,555 | $132,632,096 | |
| 7 | NTRA |
Natera, Inc.
|
491,336 | $98,262,286 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
73,125 | $92,225,250 |
All Filings in XGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,707 | 34,569 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $192,000 | 31,579 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||